Loading clinical trials...
Loading clinical trials...
Double-Blind, Randomized, Parallel Group, Multicenter Study of Durolane Compared to Methylprednisolone in Subjects With Osteoarthritis of the Knee
Conditions
Interventions
Durolane is a device, methylprednisolone in a drug
Locations
23
Canada
Alberta Bone & Joint Health Institute
Calgary, Alberta, Canada
Nexus Clinical Research
St. John's, Newfoundland and Labrador, Canada
Orthopaedic & Sport Medicine Institute of Nova Scotia
Halifax, Nova Scotia, Canada
Dr. Wilson
Lunenburg, Nova Scotia, Canada
QEII Health Sciences Centre-New Halifax Infirmary
Halifax, Ontario, Canada
Charlton Medical Centre
Hamilton, Ontario, Canada
Start Date
March 1, 2007
Primary Completion Date
January 1, 2008
Completion Date
November 1, 2008
Last Updated
August 25, 2022
NCT07351968
NCT06747494
NCT06906939
NCT07224958
NCT06721897
NCT06600958
Lead Sponsor
Galderma R&D
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions